Alpha 2.0
Login Register
» Authors » Jean Marc Tourani

Jean Marc Tourani

Explore the profile of Jean Marc Tourani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 165
Followers 0
Related Specialties
Oncology
Pharmacology
Pulmonary Medicine
Top 10 Co-Authors
Marie Claire Pinel
Etienne Lemarie
Pierre Levillain
Helene Senellart
Pierre Fumoleau
Dominique De Raucourt
Alain Baudoux
Emile Reyt
Jean Pierre Delord
Philippe Lang
Published In
Cancer
J Clin Oncol
Melanoma Res
Cancer Chemother Pharmacol
J Thorac Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study
Isambert N, Delord J, Tourani J, Fumoleau P, Ravaud A, Pinel M, et al.
Br J Clin Pharmacol . 2013 Nov; 77(3):498-508. PMID: 24283925
Aims: Vinflunine (VFL) ditartrate, a novel tubulin-targeted inhibitor, is registered for the treatment of patients with advanced or metastatic urothelial transitional cell carcinoma. This phase I study assessed the effect...
2.
Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
Tougeron D, Cortes U, Ferru A, Villalva C, Silvain C, Tourani J, et al.
Cancer Chemother Pharmacol . 2013 Jun; 72(2):397-403. PMID: 23765179
It is now well established that metastatic colorectal cancer patients without KRAS mutation (codon 12) benefit from treatment with an epidermal growth factor receptor monoclonal antibody (anti-EGFR mAb). Recently, EFGR...
3.
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study
LeFebvre J, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, et al.
J Clin Oncol . 2013 Jan; 31(7):853-9. PMID: 23341517
Purpose: To compare the efficacy and safety of induction chemotherapy (ICT) followed by chemoradiotherapy (CRT) or bioradiotherapy (BRT) for larynx preservation (LP). Patients And Methods: Previously untreated patients with stage...
4.
Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients
Tournoux-Facon C, Senellart H, Lemarie E, Tourani J, Favrel S, Pouget J, et al.
J Thorac Oncol . 2011 May; 6(7):1247-53. PMID: 21610520
Introduction: Vinflunine (Javlor) has shown significant antitumour activity in advanced non-small cell lung cancer (NSCLC). We propose to define the recommended dose of vinflunine in combination with gemcitabine for treatment...
5.
Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
Wierzbicka-Hainaut E, Sassolas B, Mourey L, Guillot B, Bedane C, Guillet G, et al.
Melanoma Res . 2010 Jan; 20(2):141-6. PMID: 20075758
Temozolomide (TMZ) is a second-generation alkylating agent that has recently shown some efficacy in stage IV melanoma. The purpose of this study was to test the efficacy and safety of...
6.
Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot
Scotte F, Banu E, Medioni J, Levy E, Ebenezer C, Marsan S, et al.
Cancer . 2008 Feb; 112(7):1625-31. PMID: 18286527
Background: Onycholysis occurs in approximately 30% of patients treated with docetaxel. The efficacy and safety of an Elasto-Gel frozen sock (FS) was investigated for the prevention of docetaxel-induced nail and...